scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00408-009-9187-X |
P698 | PubMed publication ID | 19809852 |
P2093 | author name string | Kaiser G Lim | |
P2860 | cites work | A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. | Q52136783 |
Exertional Dyspnea and Cough as Preludes to Acute Attacks of Bronchial Asthma | Q54627798 | ||
Exhaled Nitric Oxide as a Noninvasive Assessment of Chronic Cough | Q58387536 | ||
Chronic cough as the sole presenting manifestation of bronchial asthma | Q67470994 | ||
Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause | Q71064921 | ||
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999 | Q73321409 | ||
Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma | Q73726954 | ||
Airway remodelling in cough-variant asthma | Q74195259 | ||
Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma | Q77747395 | ||
"Post-nasal drip syndrome": most patients with purulent nasal secretions do not complain of chronic cough | Q79539263 | ||
Benchmarks for the assessment of novel cardiovascular biomarkers | Q79837581 | ||
Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study | Q80785572 | ||
A randomised, placebo controlled trial of inhaled salbutamol and beclomethasone for recurrent cough. | Q30494991 | ||
Reference values for exhaled nitric oxide (reveno) study. | Q30499270 | ||
Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines | Q33232249 | ||
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 | ||
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma | Q34421179 | ||
Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years | Q34424366 | ||
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines | Q34486883 | ||
Reference ranges for exhaled nitric oxide derived from a random community survey of adults | Q34625434 | ||
Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough | Q34708439 | ||
Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough | Q34789591 | ||
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment | Q35534500 | ||
Exhaled nitric oxide correlates with airway eosinophils in childhood asthma | Q35535115 | ||
Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma | Q35563919 | ||
Utility of signs and symptoms of chronic cough in predicting specific cause in children. | Q36184146 | ||
Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines | Q36374719 | ||
Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines | Q36374775 | ||
Cough variant asthma: a review of the clinical literature | Q36489909 | ||
The use of fraction of exhaled nitric oxide in pulmonary practice | Q37156091 | ||
The use and abuse of office spirometry | Q37310891 | ||
Chronic cough: Stepwise application in primary care practice of the ACCP guidelines for diagnosis and management of cough | Q37581940 | ||
Chronic cough from the patient's perspective | Q40244216 | ||
Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. | Q42442862 | ||
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study | Q42602143 | ||
A comparison of the validity of different diagnostic tests in adults with asthma. | Q43955597 | ||
Chronic cough: eosinophilic bronchitis without asthma | Q44412316 | ||
Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma | Q44447258 | ||
Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children | Q44650811 | ||
Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough. | Q46027539 | ||
Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction: the DIDASCO2 study. | Q46155655 | ||
Exhaled nitric oxide: a predictor of steroid response | Q46496987 | ||
Airway inflammation and cough sensitivity in cough-variant asthma | Q46730005 | ||
Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample | Q47314113 | ||
Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. | Q50776015 | ||
Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | Q51641626 | ||
P304 | page(s) | S19-22 | |
P577 | publication date | 2009-10-07 | |
P1433 | published in | Lung | Q15765075 |
P1476 | title | Nitric oxide measurement in chronic cough | |
P478 | volume | 188 Suppl 1 |
Search more.